Evidence map›Paper›PMID 23101492›Full record

Trial reportMalaria journal2012

In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam.

Tran Tinh Hien, Nguyen Thanh Thuy-Nhien, Nguyen Hoan Phu, Maciej F Boni, Ngo Viet Thanh, Nguyen Thuy Nha-Ca, Le Hong Thai, Cao Quang Thai, Pham Van Toi, Phung Duc Thuan and 9 more

2 registry-linked trialsOpen access · goldAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Malaria journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 100 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 5 pooled it
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01872702 nacompletednot on this mapstarted 2013, after this paper: background citation

Targeted Chemo-elimination (TCE) to Eradicate Malaria in Areas of Suspected or Proven Artemisinin Resistance in Southeast Asia and South Asia

TypeinterventionalSponsorUniversity of OxfordRan2013 to 2017Enrolled8,000ConditionsPlasmodium Falciparum MalariaArmsmalaria elimination using DP and low-dose primaquine
NCT02604966 phase4unknown statusnot on this mapstarted 2015, after this paper: background citation

Efficacy of Artesunate Monotherapy and Dihydroartemisinin - Piperaquine in Patients With Uncomplicated Falciparum Malaria in Central Vietnam

TypeinterventionalSponsorNational Institute of Malariology, Parasitology and Entomology, VietnamRan2015 to 2016Enrolled120ConditionsDrug Resistant Malaria Due to Plasmodium FalciparumArmsArtesunate (AS) group, DHA - PPQ group
3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 5 syntheses or guidelines pooled it, 145 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Antimicrobial agents and chemotherapy · 2023
    Article
  16. Article
  17. Article
  18. Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook.International journal for parasitology. Drugs and drug resistance · 2021
    Article
  19. Article
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 4 countries.

Tran Tinh HienWellcome Trust Major Overseas Programme (MOP), Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Vietnam. hientt@oucru.org
Nguyen Thanh Thuy-Nhien
Nguyen Hoan Phu
Maciej F Boni
Ngo Viet Thanh
Nguyen Thuy Nha-Ca
Le Hong Thai
Cao Quang Thai
Pham Van Toi
Phung Duc Thuan
Le Thanh Long
Le Thanh Dong
Laura Merson
Christiane Dolecek
Kasia Stepniewska
Pascal Ringwald
Nicholas J White
Jeremy Farrar
Marcel Wolbers
Oxford University Clinical Research Unit · VNNational Institute of Malariology, Parasitology and Entomology · VNNuffield Orthopaedic Centre · GBUniversity of Oxford · GBHospital for Tropical Diseases · VNWorld Health Organization · CH

Funding

Wellcome Trust 089275Wellcome Trust 089276Wellcome Trust 093956
6 · The paper itself

Abstract

backgroundBy 2009, there were worrying signs from western Cambodia that parasitological responses to artesunate-containing treatment regimens for uncomplicated Plasmodium falciparum malaria were slower than elsewhere which suggested the emergence of artemisinin resistance. Vietnam shares a long land border with Cambodia with a large number of migrants crossing it on a daily basis. Therefore, there is an urgent need to investigate whether there is any evidence of a change in the parasitological response to the artemisinin derivatives in Vietnam.

methodsFrom August 2010 to May 2011, a randomized controlled clinical trial in uncomplicated falciparum malaria was conducted to compare two doses of artesunate (AS) (2mg/kg/day versus 4 mg/kg/day for three days) followed by dihydroartemisinin-piperaquine (DHA-PPQ) and a control arm of DHA-PPQ. The goal was characterization of the current efficacy of artesunate in southern Vietnam. The primary endpoint of this study was the parasite clearance half-life; secondary endpoints included the parasite reduction ratios at 24 and 48 hours and the parasite clearance time.

results166 patients were recruited into the study. The median parasite clearance half-lives were 3.54 (AS 2mg/kg), 2.72 (AS 4mg/kg), and 2.98 hours (DHA-PPQ) (p=0.19). The median parasite-reduction ratio at 24 hours was 48 in the AS 2mg/kg group compared with 212 and 113 in the other two groups, respectively (p=0.02). The proportions of patients with a parasite clearance time of >72 hours for AS 2mg/kg, AS 4mg/kg and DHA-PPQ were 27%, 27%, and 22%, respectively. Early treatment failure occurred in two (4%) and late clinical failure occurred in one (2%) of the 55 patients in the AS 2mg/kg group, as compared with none in the other two study arms. The PCR-corrected adequate clinical and parasitological response (APCR) rates in the three groups were 94%, 100%, and 100% (p=0.04).

conclusionsThis study demonstrated faster P. falciparum parasite clearance in southern Vietnam than in western Cambodia but slower clearance in comparison with historical data from Vietnam. Further studies to determine whether this represents the emergence of artemisinin resistance in this area are needed. Currently, the therapeutic response to DHA-PPQ remains satisfactory in southern Vietnam.

trial registrationNTC01165372.

Indexed as

Drug ResistanceAdolescentAdultAntimalarialsArtemisininsArtesunateChildFemaleHumansMalaria, FalciparumMalePiperazinesPlasmodium falciparumQuinolinesTreatment OutcomeVietnamAntimalarialsArtemisininsartenimolArtesunatepiperaquinePiperazinesQuinolines

Identifiers

PMID23101492
PMCPMC3504531
OpenAlexW2132093894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.